BAKER BROS. ADVISORS LP

Q3 2025 13F Holdings

  • Location
    new york, NY
  • Num holdings

    91

  • Value ($000)

    $13,838,782

  • Date Filed
    11/14/2025
  • Form type
    13F-HR
  • CIK
    0001263508
  • All SEC filings
  • Note
    Holdings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q3 2025 to
Select Quarter
Issuer Name
Class
CUSIP
VALUE
%
Shares
Principal
Option Type
B
BGNE

BeOne Medicines Ltd.

SPONSORED ADS
07725L102
$3.00B
22 %

8,799,053

I
INCY

Incyte Corporation

COM
45337C102
$2.61B
19 %

30,743,663

M
MDGL

Madrigal Pharmaceuticals, Inc.

COM
558868105
$982.31M
7 %

2,141,701

I
INSM

Insmed Incorporated

COM PAR $.01
457669307
$965.37M
7 %

6,703,484

A
ACAD

ACADIA Pharmaceuticals Inc.

COM
004225108
$915.42M
7 %

42,896,690

S
SMMT

Summit Therapeutics Inc.

COM
86627T108
$696.72M
5 %

33,722,974

R
RYTM

Rhythm Pharmaceuticals, Inc.

COM
76243J105
$566.00M
4 %

5,604,483

R
RVMD

Revolution Medicines, Inc.

COM
76155X100
$441.57M
3 %

9,455,357

C
CELC

Celcuity Inc.

COM
15102K100
$391.04M
3 %

7,915,792

K
KYMR

Kymera Therapeutics, Inc.

COM
501575104
$376.47M
3 %

6,651,429

Rows Per Page
10
  • 10
  • 50
  • 100
1 - 10 of 91